Parathyroid hormone-related protein has an anorexigenic activity via activation of hypothalamic urocortins 2 and 3

Psychoneuroendocrinology

Volumn 35, Issue 8, 2010, Pages 1178-1186

  Asakawa, Akihiro ^a   Fujimiya, Mineko ^b   Niijima, Akira ^c   Fujino, Kazunori ^d   Kodama, Noriko ^e   Sato, Yuki ^f   Kato, Ikuo ^f   Nanba, Hiroaki ^e   Laviano, Alessandro ^g   Meguid, Michael M ^h   Inui, Akio ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b SAPPORO MEDICAL UNIVERSITY   (Japan)

^c NIIGATA UNIVERSITY   (Japan)

^d SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^e KOBE PHARMACEUTICAL UNIVERSITY   (Japan)

^f HOKURIKU UNIVERSITY   (Japan)

^g SAPIENZA UNIVERSITY OF ROME   (Italy)

^h SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

Author keywords

Cachexia; Feeding behavior; Gut motility; Hypothalamus; Parathyroid hormone related protein; Vagal nerve

Indexed keywords

PARATHYROID HORMONE RELATED PROTEIN; UROCORTIN II; UROCORTIN III;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; ENERGY BALANCE; FEMALE; FOOD INTAKE; GASTROINTESTINAL MOTILITY; GENE EXPRESSION; HYPOTHALAMUS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; STOMACH EMPTYING; TASTE AVERSION; VAGUS TONE; WEIGHT GAIN;

EID: 77955563588     PISSN: 03064530     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2010.02.003     Document Type: Article

References (33)

1. Asakawa A., Inui A., Kaga T., Yuzuriha H., Nagata T., Ueno N., Makino S., Fujimiya M., Niijima A., Fujino M.A., Kasuga M. Ghrelin is an appetite-stimulatory signal from stomach with structural resemblance to motilin. Gastroenterology 2001, 120:337-345.
2. Bernstein I.L., Goehler L.E., Bouton M.E. Relative potency of foods and drinks as targets in aversion conditioning. Behav. Neural. Biol. 1983, 37:134-148.
3. Burtis W.J., Wu T., Bunch C., Wysolmerski J.J., Insogna K.L., Weir E.C., Broadus A.E., Stewart A.F. Identification of a novel 17,000-dalton parathyroid hormone-like adenylate cyclase-stimulating protein from a tumor associated with humoral hypercalcemia of malignancy. J. Biol. Chem. 1987, 262:7151-7156.
4. Burtis W.J., Brady T.G., Orloff J.J., Ersbak J.B., Warrell, Olson B.R., Wu T.L., Mitnick M.E., Broadus A.E., Stewart A.F. Immunochemical characterization of circulating parathyroid hormone-related protein in patients with humoral hypercalcemia of cancer. N. Engl. J. Med. 1990, 322:1106-1112.
5. Chen C.Y., Inui A., Asakawa A., Fujino K., Kato I., Chen C.C., Ueno N., Fujimiya M. Des-acyl ghrelin acts by CRF type 2 receptors to disrupt fasted stomach motility in conscious rats. Gastroenterology 2005, 129:8-25.
6. Czimmer J., Million M., Tache Y. Urocortin 2 acts centrally to delay gastric emptying through sympathetic pathways while CRF and urocortin 1 inhibitory actions are vagal dependent in rats. Am. J. Physiol. 2006, 290:G511-G518.
7. Dautzenberg F.M., Hauger R.L. The CRF peptide family and their receptors: yet more partners discovered. Trends Pharmacol. Sci. 2002, 23:71-77.
8. Duggan J.P., Booth D.A. Obesity, overeating, and rapid gastric emptying in rats with ventromedial hypothalamic lesions. Science 1986, 231:609-611.
9. Flier J.S., Maratos-Flier E. Obesity and the hypothalamus: novel peptides for new pathways. Cell 1998, 92:437-440.
10. Forero A., Lobuglio A.F. History of antibody therapy for non-Hodgkin's lymphoma. Semin. Oncol. 2003, 30:1-5.
11. Fujino K., Inui A., Asakawa A., Kihara N., Fujimura M., Fujimiya M. Ghrelin induces fasted motor activity of the gastrointestinal tract in conscious fed rats. J. Physiol. 2003, 550:227-240.
12. Gaich G., Burtis W.J. Measurement of circulating parathyroid hormone-related protein in rats with humoral hypercalcemia of malignancy using a two-site immunoradiometric assay. Endocrinology 1990, 127:1444-1449.
13. Geary N., Le Sauter J., Noh U. Glucagon acts in the liver to control spontaneous meal size in rats. Am. J. Physiol. 1993, 264:R116-R122.
14. Harvey K.B., Bothe A., Blackburn G.L. Nutritional assessment and patient outcome during oncological therapy. Cancer 1979, 43:2065-2069.
15. Hsu S.Y., Hsueh A.J. Human stresscopin and stresscopin-related peptide are selective ligands for the type 2 corticotropin-releasing hormone receptor. Nat. Med. 2001, 7:605-611.
16. Iguchi H., Aramaki Y., Maruta S., Takiguchi S. Effects of anti-parathyroid hormone-related protein monoclonal antibody and osteoprotegerin on PTHrP-producing tumor-induced cachexia in nude mice. J. Bone Miner. Metab. 2006, 24:16-19.
17. Inui A. Cancer anorexia-cachexia syndrome: current issues in research and management. C. A. Cancer J. Clin. 2002, 52:72-91.
18. Inui A., Asakawa A., Bowers C.Y., Mantovani G., Laviano A., Meguid M.M., Fujimiya M. Ghrelin, appetite, and gastric motility: the emerging role of the stomach as an endocrine organ. FASEB J. 2004, 18:439-456.
19. Karaplis A.C., Luz A., Glowacki J., Bronson R.T., Tybulewicz V.L., Kronenberg H.M., Mulligan R.C. Lethal skeletal dysplasia from targeted disruption of the parathyroid hormone-related peptide gene. Genes Dev. 1994, 8:277-289.
20. Koda S., Date Y., Murakami N., Shimbara T., Hanada T., Toshinai K., Niijima A., Furuya M., Inomata N., Osuye K., Nakazato M. The role of the vagal nerve in peripheral PYY3-36-induced feeding reduction in rats. Endocrinology 2005, 146:2369-2375.
21. Moseley J.M., Kubota M., Diefenbach-Jagger H., Wettenhall R.E., Kemp B.E., Suva L.J., Rodda C.P., Ebeling P.R., Hudson P.J., Zajac J.D., Martin T.J. Parathyroid hormone-related protein purified from a human lung cancer cell line. Proc. Natl. Acad. Sci. U.S.A. 1987, 84:5048-5052.
22. Niijima A., Meguid M.M. An electrophysiological study on amino acid sensors in the hepato-portal system in the rat. Obes. Res. 1995, 3:741S-745S.
23. Ohata H., Shibasaki T. Effects of urocortin 2 and 3 on motor activity and food intake in rats. Peptides 2004, 25:1703-1709.
24. Onuma E., Tsunenari T., Saito H., Sato K., Yamada-Okabe H., Ogata E. Parathyroid hormone-related protein (PTHrP) as a causative factor of cancer-associated wasting: possible involvement of PTHrP in the repression of locomotor activity in rats bearing human tumor xenografts. Int. J. Cancer 2005, 116:471-478.
25. Pardo F.S., Lien W.W., Fox H.S., Efird J.T., Aguilera J.A., Burton D.W., Deftos L.J. Parathyroid hormone-related protein expression is correlated with clinical course in patients with glial tumors. Cancer 2004, 101:2622-2628.
26. Sato K., Onuma E., Yocum R.C., Ogata E. Treatment of malignancy-associated hypercalcemia and cachexia with humanized anti-parathyroid hormone-related protein antibody. Semin. Oncol. 2003, 30:167-173.
27. Schnell F.M. Chemotherapy-induced nausea and vomiting: the importance of acute antiemetic control. The Oncologist 2003, 28:187-198.
28. Schwartz M.W., Woods S.C., Porte D.D.J., Seeley R.J., Baskin D.G. Central nervous system control of food intake. Nature 2000, 404:661-671.
29. Strewler G.J., Stern P.H., Jacobs J.W., Eveloff J., Klein R.F., Leung S.C., Rosenblatt M., Nissenson R.A. Parathyroid hormonelike protein from human renal carcinoma cells. Structural and functional homology with parathyroid hormone. J. Clin. Invest. 1987, 80:1803-1807.
30. Strewler G.J. The physiology of parathyroid hormone-related protein. N. Engl. J. Med. 2000, 342:177-185.
31. Toomey D., Redmond P., Bouchier-Hayes D. Mechanisms mediating cancer cachexia. Cancer 1995, 76:2418-2426.
32. Vaughan J., Donaldson C., Bittencourt J., Perrin M.H., Lewis K., Sutton S., Chan R., Turnbull A.V., Lovejoy D., Rivier C. Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor. Nature 1995, 378:287-292.
33. Zhang J.V., Ren P.G., Avsian-Kretchmer O., Luo C.W., Rauch R., Klein C., Hsueh A.J. Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake. Science 2005, 5750:996-999.